Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,500
Avg Vol 2,266
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 42%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replac...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 905-206-0013
Fax: 905-206-1413
Address:
2476 Argentia Road, Suite 402, Mississauga, Canada
BaronMerah
BaronMerah May. 6 at 3:29 PM
$BIOYF no updates 😢
0 · Reply
FinJay
FinJay May. 1 at 3:52 AM
$BIOYF https://youtu.be/_RZfbD-60dE
0 · Reply
BaronMerah
BaronMerah Apr. 14 at 4:56 PM
$BIOYF no price updates
0 · Reply
newsfile_corp
newsfile_corp Apr. 4 at 9:01 PM
https://nfne.ws/247398 $BIOYF $RX.TSXV #InvitationalXIV #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing
0 · Reply
Latest News on BIOYF
No data available.
BaronMerah
BaronMerah May. 6 at 3:29 PM
$BIOYF no updates 😢
0 · Reply
FinJay
FinJay May. 1 at 3:52 AM
$BIOYF https://youtu.be/_RZfbD-60dE
0 · Reply
BaronMerah
BaronMerah Apr. 14 at 4:56 PM
$BIOYF no price updates
0 · Reply
newsfile_corp
newsfile_corp Apr. 4 at 9:01 PM
https://nfne.ws/247398 $BIOYF $RX.TSXV #InvitationalXIV #ldmicro #Publishing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing
0 · Reply